key: cord-0970974-qejwmsu3 authors: Pascarella, Stefano; Ciccozzi, Massimo; Zella, Davide; Bianchi, Martina; Benetti, Francesca; Broccolo, Francesco; Cauda, Roberto; Caruso, Arnaldo; Angeletti, Silvia; Giovanetti, Marta; Cassone, Antonio title: SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate? date: 2021-06-09 journal: bioRxiv DOI: 10.1101/2021.06.08.445535 sha: ce0c596cb911b6b75ae9e9c9a75a84f60794ab0f doc_id: 970974 cord_uid: qejwmsu3 Lineage B.1.617+, also known as G/452R.V3, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1, B.1.617.2 and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particular concern: E484Q, L452R and P681R. Here we report a major effect of the mutations characterizing this lineage, represented by a marked alteration of the surface electrostatic potential (EP) of the Receptor Binding Domain (RBD) of the spike protein. Enhanced RBD-EP is particularly noticeable in the B.1.617.2 sublineage, which shows multiple replacements of neutral or negatively-charged amino acids with positively-charged amino acids. We here hypothesize that this EP change can favor the interaction between the B.1.617+RBD and the negatively-charged ACE2 thus conferring a potential increase in the virus transmission. The Coronavirus Disease 19 , caused by the new coronavirus SARS-CoV-2, continues to spread worldwide, with more than 163 million infections and about 3,5 million deaths as of May 17 th , 2021 (www.who.int). In order to fight this dreadful disease, several safe and efficacious vaccines against SARS-CoV-2 are being used with remarkable effectiveness in some countries and limited availability in others. In particular, the capacity of some countries to halt SARS-CoV-2 spread is still limited due to inadequate resources and vaccination infrastructures (1, 2) . In this scenario, several SARS-CoV-2 variants have been identified and have become a global threat. Some of them have been classified as variants of concern (VOCs) due to their mutations in the S1 subunit of the spike (S) protein, particularly in its receptor binding domain (RBD) (3) (4) (5) . One of them, identified as B.1.1.7, also known as the UK variant, bears a substitution of asparagine with tyrosine on the position 501 and a deletion of two amino acids in the position 69-70 of the S1 subunit. This variant has quickly spread in several European countries to become globally dominant (5) . Others VOCs have been isolated in South Africa and Brazil and have been studied for their enhanced contagiousness and resistance to neutralization by antibodies from convalescent and vaccine-recipient subjects (6-8) ( Table 1) . Quite recently, a new variant under investigation (VUI) has been isolated from Maharashtra, India, in a setting of highly diffusive epidemic with devastating proportions (. This variant, identified as B.1.617 carries several non-synonymous mutations. Two of them, the E484Q (or the P478K) and the L452R, are located in the RBD region, and they are critical site for the binding with ACE2. Initial data suggest these mutations could confer increased transmission and immune-evasion (9) (10) (11) In order to perform more robust analysis 3 different 3-dimensional structures of SARS-CoV-2 Spike Glycoprotein have been downloaded from Protein Data Bank with the following characteristics: 1. SARS-CoV-2 RBD in complex with neutralizing antibody CC12.3 (PDB code: 6XC4 chain A) 2. SARS-CoV-2 Spike Glycoprotein whole structure (PDB code: 6XR8 chain E) 3. SARS-CoV-2 RBD in complex with ACE2-B0AT1 (PDB code: 6M17 chain F). The DynaMut server (12) has been used to predict the impact of mutations on protein stability analyzing the folding free energy (ΔΔG) and the Vibrational movement (ΔΔS), two crucial characteristics of the function and the molecular recognition of the protein. PyMol (PyMol, version 2.4) suite was utilized for in-silico mutagenesis and its Adaptive Poisson-Boltzmann Solver (APBS) plugin (13) has been used to calculate the electrostatic potential of the wild-type and VOCs SARS-CoV-2 Spike Receptor Binding Domain (RBD) and evaluate potential differences in terms of molecular interaction with ACE2 receptor. The results have been reported within a range between -5 kT/e and +5 kT/e. In silico prediction of the mutation impact on the RBD stability has been carried out with DynaMut. Three alternative RBD structures denoted by the PDB codes 6M17, 6M0J and 6XC4 have been tested. These structures display small differences in the conformation of loops, especially in the one inside the Receptor Binding Motif (RBM). According to the parameters of our in silico experiments, the output of DynaMut for mutant sites within loops differ depending on the starting loop conformation. For this reason, we used a normalized procedure, whereby the same mutation has been tested in each of the three different RBD structures. The effect on stability, de-or stabilization, has been evaluated following a majority criterion. Detailed results have been reported in Table 1 . Starting with position 501 within a loop in the RDB interacting with ACE2 receptor, we note that the mutation N501Y does not show any unambiguous structural effect and should be considered neutral ( Table 1) . Also, position 417 is within the interface α -helix where Lys interacts with ACE2 Asp30. However, in this case, our results predict that both mutants (K417N and K417T) could destabilize the protein and increase local flexibility. Similarly, Glu484 is in an interfacial loop and interacts with ACE2 Lys31. Again, our data predict that both mutations (E484K and E484Q) exert a destabilizing effect, with E484Q being the strongest. We note that Glutamic Acid is a polar, negatively charged, hydrophilic amino acid while Lysine is basic, chiral, charged and aliphatic amino acid and its ε -amino group often participates in hydrogen bonding, salt bridges and covalent interactions. Both mutants E484K and E484Q, would likely increase local molecular flexibility. L452 is in a short β -strand and it is exposed to the solvent. Apparently, it does not interact directly with ACE2. Mutation L452R is predicted to be destabilizing with increased local flexibility. Position 478 is in a loop in proximity of the ACE2 although not in direct contact with it. The mutation T478K is stabilizing and predicted to decrease local protein flexibility. The entire set of mutations in position 417, 452, 478, 484 and 501 are in the Spike RBD at the interface with the ACE2 N-terminal helix (Figure 1) . However, we note that the mutant positions 452, 478, 484 and 501 are within the RBM, containing residues that bind to ACE2. On the other hand, the mutant position 417 is located outside the motif (14) . According to our analysis, the mutations in position 417, 484 and 501 might alter the Spike binding affinity with the ACE2 receptor. In particular, the Tyr replacing Asn501 may form an aromatic interaction with ACE2 Tyr41, a hydrogen bond with ACE2 D38 and a potential cation-π interaction with ACE2 Lys353. In addition, substitutions of Glu484 with Lys or Gln may form hydrophobic interactions to Ile472, Gly482, Phe486, Cys488 and Tyr489. Our data also indicate that replacing Lys or Gln with Glu484 abolishes the interfacial salt bridge between Glu484 and ACE2 Lys31. Due to the fact that Lys417 is solvent-exposed and forms salt-bridge interactions with Asp30 of ACE2, (Figure 2 ). Given that SARS-CoV-2 variants are characterized by evolutionary and genetic changes accumulated in the genome, the use of new and improved phylodynamic techniques for the study of how epidemiological, immunological, and evolutionary processes contribute to shaping viral phylogenies is extremely important and useful. Here using a well-structured software workflow we provide evidence of a strong system able to carry out a quick, systematic and reproducible screening of the SARS-CoV-2 genome isolates. Protein mutations were identified by scanning high-quality SARS-CoV-2 genomes variants downloaded from GISAID databank (15) . We reasoned that the most likely health-threatening properties of SARS-CoV-2 VOC rely on fine biochemical and biophysical changes that eventually impact the RBD interaction with the ACE2 receptor present on the host's cell surface. We thus characterized B.1.617+ SARS-CoV-2 VUI using in-silico methods capable of predicting the effect of mutations on S-RBD protein stability and its electrostatic potential. The B.1.617+ mutations have been investigated by comparing most of the already known mutations of previously reported VOCs (16) . To further justify our assumption, we note that the intensely investigated D614G substitution of the spike protein, early reported in Italian isolates (17, 18, 19) , and subsequently attributed with increased virus transmissibility (20) was found to enhance the protein torsional ability and potentially affecting its stability (20) . Although initially believed to enhance the antibody-escape potential, it has been shown that the B.1.617.1 subvariant is pretty neutralized by the majority of sera from convalescent individuals and all sera from vaccinated subjects (24) . Nonetheless, this variant has been shown to be more pathogenic than the B.1.1.7 variant in an experimental model of SARS-CoV-2 infection in hamsters (25) . Our data indicate that most of the mutants are predicted to destabilize the RBD structure, except for T478K. It is thus conceivable that with destabilization comes altered binding affinity to ACE2 and to neutralizing antibodies. As noticed above, the influence of the mutations on the Spike surface properties is particularly evident in the B.1.617+ lineage, particularly for the B.1.617.2 lineage component, where the positive electrostatic surface potential is markedly increased. This may favor RBD interaction with the negatively charged ACE2 (26) , which in turn would then increase affinity for the ACE2 receptor. All of these changes have the potential to eventually modify infectivity, pathogenicity and virus spread. Regarding differential binding to neutralizing antibodies, previous studies suggested that VOCs RBDs changes in the electrostatic potential surface could induce SARS-CoV-2 antibody evasion and even single amino acid changes that marginally affect ACE2 affinity could greatly influence nAbs affinity (27) . Several factors have been demonstrated to affect the impact of VOCs. For example, it has been observed an increased effect at pH associated with nasal secretions (from 5.5 to 6.5) (28). A novel coronavirus outbreak of global health concern How COVID vaccines are being divided up around the world SARS-CoV-2 variants and ending the COVID-19 pandemic Structure analysis of the receptor binding of 2019-nCoV Emergence of SARS-CoV-2 B Safety and efficacy of the vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Transmission of SARS-CoV-2 lineage B.1.1.7 in England: insights from linking epidemiological and genetic data Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England Science SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant bioRxiv preprint doi Bo Meng Partha4 Rakshit4 ,et al SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies BioRxiv preprint doi SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades 2 antibodies induced by infection and vaccinationdoi: bioRxiv preprint DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability Electrostatics of nanosystems: application to microtubules and the ribosome Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor SARS-Cov-2 ORF3a: Mutability and function Detection of a SARS-CoV-2 variant of concern in South Africa Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant Spike mutation D614G alters SARS-CoV-2 fitness Variants: distribution of cases data -GOV Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera Epub ahead of print Comparative infectivity and pathogenesis of emerging SARS-CoV-2 variants in Syrian 2 hamsters Fight against novel coronavirus: A perspective of medicinal chemists SP has been partially supported by the Sapienza grant RP120172B49BE24. Authors are grateful to Alice Vinciguerra for her precious assistance. We also would like to thank all the authors who have kindly deposited and shared genome data on GISAID.